ArticleCommunications biology2025
Early-phase impact of obesity-associated stress on murine vascular smooth muscle cells depends on EGFR and sex.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Obesity leads to vascular dysfunction mediated partially by the vascular smooth muscle cell (VSMC) EGF-receptor (EGFR). We investigate the impact of obesity-associated metabolic and humoral stress on primary murine VSMC with conditional EGFR knockout (KO) and wildtype (WT) VSMC, focusing on early-phase impact to test the hypothesis of an EGFR-dependent stressor synergism. Cells are exposed to three stress conditions (high glucose + free fatty acids; angiotensinII + noradrenaline; combined = all stressors) and bulk RNA-sequencing with bioinformatics analysis, followed by phenotypical assessment is performed. RNASeq-results show stressor synergy in male WT-VSMC but not in KO VSMC or endothelial cells (EC). Bioinformatic analysis predicts dysregulation of functions related to DNA-synthesis/cell cycle, lipid handling, contraction and motility for male WT-VSMC. Functional validation confirms synergy concerning DNA-synthesis and lipid accumulation in male WT-VSMC but not in female WT-VSMC. Altered contraction or motility are not confirmed. Male WT-VSMC show higher EGFR-expression than female WT-VSMC and respond with enhanced SRF
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.